The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats by Modifying the Serum Fatty Acid Composition and by Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue
Table 4
Effect of RSV + QRC administration on seric nonesterified fatty acids (NEFAs) composition from control and MetS rats.
NEFAs %
Control
MetS
Without treatment
RSV 10 + QRC 0.19 mg/kg/day
RSV 50 + QRC 0.95 mg/kg/day
Without treatment
RSV 10 + QRC 0.19 mg/kg/day
RSV 50 + QRC 0.95 mg/kg/day
Palmitic acid
34.9 ± 1.3
32.5 ± 1.4
33.6 ± 0.9
33.6 ± 0.8
32.8 ± 0.9
33.6 ± 0.7
Palmitoleic acid
6.2 ± 0.9
5.3 ± 0.8
5.1 ± 0.9
13.1 ± 0.8
11.6 ± 0.5
10.9 ± 0.5
Stearic acid
22.2 ± 0.5
24.1 ± 0.7
23.1 ± 0.8
16.2 ± 0.5
19.2 ± 1.1
19.8 ± 0.5
Oleic acid
17.8 ± 1.0
19.4 ± 1.0
18.6 ± 0.9
22.5 ± 0.9
23.0 ± 0.5
21.9 ± 0.5
Linoleic acid
13.7 ± 1.4
14.3 ± 0.6
13.9 ± 0.9
8.8 ± 0.3
8.1 ± 0.4
9.0 ± 0.4
-linoleic acid
1.3 ± 0.2
1.4 ± 0.3
1.4 ± 0.3
1.6 ± 0.3
1.1 ± 0.2
1.2 ± 0.3
Dihomo--linoleic acid
0.7 ± 0.08
0.8 ± 0.1
0.6 ± 0.07
0.5 ± 0.1
0.4 ± 0.05
0.6 ± 0.07
Arachidonic acid
3.1 ± 0.5
2.4 ± 0.2
3.9 ± 0.4
2.1 ± 0.3
3.1 ± 0.7
2.5 ± 0.3
SFA
57.2 ± 1.6
56.7 ± 1.6
56.7 ± 0.9
49.8 ± 0.9
52.0 ± 1.05
53.4 ± 1.1
MUFA
22.6 ± 1.4
24.6 ± 1.1
23.7 ± 0.6
36.2 ± 0.9
34.3 ± 0.6
32.4 ± 0.8
PUFA
17.6 ± 0.9
18.7 ± 0.6
19.8 ± 1.3
13.5 ± 0.7
13.7 ± 1.1
14.1 ± 1.1
SFA: saturated fatty acid, MUFA: monounsaturated fatty acid, and PUFA: Polyunsaturated fatty acid. Data are mean ± SEM. ; MetS without treatment versus control without treatment; MetS without treatment versus control without treatment; against same group without treatment.
